Position in MNKD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,008,640
-$416,108 QoQ
Shares Held
236,770
-59.3% QoQ
Ownership
0.074%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#62
of 254 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MNKD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Rafferty Asset Management, LLC holds $331,711,589 across 163 Biotechnology names. MNKD ranks #87 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
65,798 | $32,683,840 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
38,534 | $24,027,490 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
55,332 | $16,656,591 | |
| 4 | MRNA |
Moderna, Inc.
|
111,906 | $7,836,777 | |
| 5 | INCY |
Incyte Corp
|
44,663 | $5,062,997 | |
| 6 | APGE |
Apogee Therapeutics, Inc.
|
33,369 | $4,429,067 | |
| 7 | ORKA |
Oruka Therapeutics, Inc.
|
43,110 | $4,102,778 | |
| 8 | KYMR |
Kymera Therapeutics, Inc.
|
35,287 | $4,046,360 |
All Filings in MNKD
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,008,640 | 236,770 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,424,748 | 581,530 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,565,504 | 452,470 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,124,649 | 209,432 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $880,010 | 235,297 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,327,668 | 263,950 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,003,292 | 311,554 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,978,701 | 314,579 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,828,920 | 350,368 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $3,316,462 | 732,111 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $2,974,291 | 817,113 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $3,534,458 | 855,801 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $4,820,324 | 1,184,355 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $5,669,767 | 1,382,870 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $6,757,178 | 1,282,197 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $4,497,859 | 1,455,618 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,630,401 | 427,927 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $3,262,507 | 886,551 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $3,635,774 | 831,985 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $2,282,458 | 524,703 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $3,510,230 | 644,079 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $3,306,508 | 843,497 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $236,518 | 75,565 | Shares | Sole | 2021-02-10 | |
| No filing history on record for this holder in this stock. | ||||||